Biomerieux SA (BIM) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.115x

Based on the latest financial reports, Biomerieux SA (BIM) has a cash flow conversion efficiency ratio of 0.115x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€470.80 Million ≈ $550.41 Million USD) by net assets (€4.11 Billion ≈ $4.80 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Biomerieux SA to measure how much of total assets are equity-financed.

Biomerieux SA - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Biomerieux SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Biomerieux SA to evaluate the quality of earnings relative to operating cash generation.

Biomerieux SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biomerieux SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
UNICHARM CORP. SP.ADR 1 F:UN41	0.047x
Primerica Inc NYSE:PRI	0.062x
Giant Network Group Co Ltd SHE:002558	0.077x
Orion Oyj B HE:ORNBV	0.086x
Alpha Services and Holdings S.A. AT:ALPHA	0.143x
SRF Limited NSE:SRF	0.080x
Vienna Insurance Group AG VI:VIG	0.020x
Tongwei Co Ltd SHG:600438	0.101x

Annual Cash Flow Conversion Efficiency for Biomerieux SA (2005–2025)

The table below shows the annual cash flow conversion efficiency of Biomerieux SA from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see BIM stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€4.11 Billion ≈ $4.80 Billion	€788.30 Million ≈ $921.61 Million	0.192x	+21.15%
2024-12-31	€4.21 Billion ≈ $4.92 Billion	€667.30 Million ≈ $780.14 Million	0.158x	+33.50%
2023-12-31	€3.75 Billion ≈ $4.39 Billion	€445.40 Million ≈ $520.72 Million	0.119x	-8.98%
2022-12-31	€3.64 Billion ≈ $4.26 Billion	€475.10 Million ≈ $555.44 Million	0.130x	-49.13%
2021-12-31	€3.16 Billion ≈ $3.70 Billion	€811.10 Million ≈ $948.26 Million	0.256x	+9.16%
2020-12-31	€2.48 Billion ≈ $2.90 Billion	€582.80 Million ≈ $681.35 Million	0.235x	+29.82%
2019-12-31	€2.25 Billion ≈ $2.64 Billion	€407.90 Million ≈ $476.88 Million	0.181x	-9.40%
2018-12-31	€2.00 Billion ≈ $2.34 Billion	€399.80 Million ≈ $467.41 Million	0.200x	+1.62%
2017-12-31	€1.74 Billion ≈ $2.03 Billion	€341.30 Million ≈ $399.02 Million	0.197x	-5.06%
2016-12-31	€1.62 Billion ≈ $1.90 Billion	€335.60 Million ≈ $392.35 Million	0.207x	+0.33%
2015-12-31	€1.50 Billion ≈ $1.76 Billion	€310.00 Million ≈ $362.42 Million	0.206x	-3.96%
2014-12-31	€1.39 Billion ≈ $1.62 Billion	€298.30 Million ≈ $348.74 Million	0.215x	+13.19%
2013-12-31	€1.27 Billion ≈ $1.48 Billion	€240.50 Million ≈ $281.17 Million	0.190x	-11.89%
2012-12-31	€1.20 Billion ≈ $1.40 Billion	€258.50 Million ≈ $302.21 Million	0.215x	+9.72%
2011-12-31	€1.10 Billion ≈ $1.29 Billion	€216.60 Million ≈ $253.23 Million	0.196x	-3.71%
2010-12-31	€976.10 Million ≈ $1.14 Billion	€199.00 Million ≈ $232.65 Million	0.204x	-12.83%
2009-12-31	€806.40 Million ≈ $942.77 Million	€188.60 Million ≈ $220.49 Million	0.234x	-18.64%
2008-12-31	€688.40 Million ≈ $804.81 Million	€197.90 Million ≈ $231.37 Million	0.287x	-8.39%
2007-12-31	€601.30 Million ≈ $702.98 Million	€188.70 Million ≈ $220.61 Million	0.314x	+40.41%
2006-12-31	€557.50 Million ≈ $651.78 Million	€124.60 Million ≈ $145.67 Million	0.223x	-32.27%
2005-12-31	€498.50 Million ≈ $582.80 Million	€164.50 Million ≈ $192.32 Million	0.330x	--

About Biomerieux SA

PA:BIM France Diagnostics & Research

Market Cap

$10.01 Billion

€8.56 Billion EUR

Market Cap Rank

#2514 Global

#51 in France

Share Price

€72.60

Change (1 day)

+0.48%

52-Week Range

€66.60 - €128.30

All Time High

€138.61